Study Watch vs Cardiomo
AI Verdict
Choose Study Watch if…
Choose Study Watch if you are conducting clinical research trials or observational studies that require a highly durable, prescription-only wrist wearable with an e-ink display to capture continuous multi-sensor data, including on-demand single-channel ECG and electrodermal activity, directly integrated into a secure cloud platform. It is ideal for research partnerships in neurology, sleep medicine, and cardiology where long-term patient compliance and robust internal data encryption are paramount.
View Study Watch →Choose Cardiomo if…
Choose Cardiomo if you need a continuous, medical-grade wearable patch designed for remote patient monitoring and real-time clinical alerts in geriatrics or general cardiology. It is best suited for active patient care and caregiving scenarios that require immediate detection of cardiovascular events, respiration rates, skin temperature, and fall detection, all delivered through a consumer-friendly mobile application.
View Cardiomo →When choosing between these two remote monitoring solutions, physicians must consider their primary clinical objective. Verily Study Watch is a prescription-only, wrist-worn wearable designed specifically for clinical research and precision health partnerships, excelling at continuous physiological data collection including on-demand single-channel ECG, electrodermal activity, and inertial movements. In contrast, Cardiomo is a wearable patch and AI-powered platform optimized for active remote patient monitoring and disease detection, specializing in real-time alerts for cardiovascular events, respiration, skin temperature, and fall detection.
The key practical difference lies in their deployment and clinical focus. Verily Study Watch acts as an encrypted data-gathering tool that feeds into Verily’s cloud-based machine learning platform for research analysis. Cardiomo operates as a direct-to-caregiver alert system, utilizing a mobile application and a wearable patch to actively detect arrhythmias and notify users of immediate health events. Researchers and institutions conducting clinical trials should select Study Watch, while clinicians seeking an active, alert-driven remote monitoring tool for geriatrics or cardiology patients should opt for Cardiomo.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch | Cardiomo |
|---|---|---|
| Pricing | Not publicly available (device for clinical research and partnerships) | Contact for pricing |
| Deployment | Cloud (data uploaded from device to Verily's cloud platform). | Cloud-based with wearable device and mobile app |
| FDA Status | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo offers a highly accessible consumer-and-caregiver-friendly experience featuring dedicated mobile applications for both iOS and Android, alongside real-time alerts and fall detection [1.2.2]. In contrast, the Verily Study Watch is a prescription-only investigational device designed primarily for clinical research cohorts, making it less adaptable for direct, everyday patient-caregiver usability.
Clinical Value
Study WatchVerily Study Watch has achieved multiple FDA 510(k) clearances, including specific clearances for its on-demand single-channel ECG and its irregular pulse monitor. It is backed by robust, peer-reviewed clinical validation studies published in major journals like the Journal of the American Heart Association, whereas Cardiomo lacks equivalent documented FDA clearances and published large-scale clinical trials.
Pricing & Value
CardiomoCardiomo has a history of transparent pricing structures, previously offering its hardware at $200 with a $10 monthly subscription, making it highly cost-effective for continuous monitoring. Verily Study Watch does not make its pricing publicly available, as it is restricted to institutional partnerships, clinical trials, and prescription-only research deployments.
Enterprise Readiness
Study WatchVerily (an Alphabet company) possesses a massive, highly secure cloud infrastructure specifically designed to handle large-scale clinical trials and institutional research partnerships. While both tools support HIPAA compliance and BAAs, Verily's extensive corporate backing, established legal frameworks, and deep integration with clinical research pipelines give it a clear edge in enterprise-grade deployments.
Innovation
Study WatchThe Study Watch features advanced hardware engineering, including an ultra-low-power E-ink display that enables a week of battery life while continuously collecting complex multi-sensor data (ECG, EDA, and inertial movements). Verily's sophisticated machine learning algorithms process these diverse physiological signals in the cloud, representing a more advanced research-grade AI architecture.
Support & Docs
Study WatchAs an established player in clinical research backed by Alphabet, Verily provides extensive, highly structured documentation, regulatory filings, and dedicated support frameworks for clinical trial investigators. Cardiomo, as a smaller startup, offers less comprehensive public documentation and institutional support resources for large-scale clinical deployments.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch | Cardiomo |
|---|---|---|
| Company | Verily Life Sciences | Cardiomo, Inc. |
| Specialties | Cardiology, Neurology, Sleep Medicine | Cardiology, Geriatrics, Internal Medicine |
| Key Features | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption | Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days) |
Videos
Demos, reviews, and walkthroughs featuring Study Watch and Cardiomo.